why choose us

First received: July 25, 2022

Clinical Trial: The Effect of IVA for Preventing Postvitrectomy Hemorrhage in PDR

Study Status: Completed

Recruit Status: Completed

Condition: Proliferative Diabetic Retinopathy

Study Type: Interventional


Official Title: The Effect of Adjunctive Intravitreal Aflibercept for Preventing Postvitrectomy Hemorrhage in Proliferative Diabetic Retinopathy

Brief Summary: Aflibercept, a recombinant fusion antibody that binds to all subtypes of VEGF and PlGF, has been shown to induce effective regression of retinal neovascularization secondary to PDR but there had been lack of a well-structured prospective study about adjunctive use of intravitreal injection of Aflibercept (IVA) to reduce postoperative VH in PPV for PDR. In this study, we aim to assess the effect of preoperative IVA on the incidence of postoperative VH after PPV for PDR.

Read more